LUNG — Pulmonx Corp
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2020-10-01.
Performance
Technicals
Others in Healthcare
Measured signals that fired on LUNG
| date | signal | measured base rate |
|---|---|---|
| 2026-06-03 | Cluster sale: three or more insiders insider | -0.37% over 21 days · t = -3.38 · n = 21,542 statistically distinguishable from its control group |
| 2026-03-04 | Cluster sale: three or more insiders insider | -0.37% over 21 days · t = -3.38 · n = 21,542 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-06-05 | Mead Dana G Jr. Director | Grant or award | 40.0K | 0.00 | 0 |
| 2026-06-05 | Burns Thomas William Director | Grant or award | 40.0K | 0.00 | 0 |
| 2026-06-05 | Ferrari Richard Director | Grant or award | 40.0K | 0.00 | 0 |
| 2026-06-05 | Melenikiotou Georgia Director | Grant or award | 40.0K | 0.00 | 0 |
| 2026-06-05 | Sullivan Tiffany Director | Grant or award | 40.0K | 0.00 | 0 |
| 2026-06-05 | Florin Daniel P Director | Grant or award | 40.0K | 0.00 | 0 |
| 2026-06-02 | French Glendon E. III President and CEO | Open-market sale | 13.5K | 1.57 | 21.2K |
| 2026-06-01 | French Glendon E. III President and CEO | Open-market sale | 38.5K | 1.54 | 59.2K |
| 2026-06-01 | Radhakrishnan Srikanth Chief Science &Techn. Officer | Open-market sale | 6.0K | 1.54 | 9.2K |
| 2026-06-01 | Lehman David Aaron GENERAL COUNSEL | Open-market sale | 4.9K | 1.54 | 7.6K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ | 6.1M | 4.7M |
| MORGAN STANLEY | 5.2M | 4.0M |
| Soleus Capital Management, L.P. | 3.6M | 2.8M |
| BlackRock, Inc. | 3.4M | 2.7M |
| ExodusPoint Capital Management, LP | 2.5M | 1.9M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.1M | 1.6M |
| BANK OF AMERICA CORP /DE/ | 1.5M | 1.2M |
| DEUTSCHE BANK AG\ | 1.5M | 1.2M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.2M | 944.5K |
| STATE STREET CORP | 1.0M | 809.1K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Ask the AI about LUNG
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →